Q1/2024 3/31/2024 EPS -0.060 ZacksConsensus -0.260 ActVsEst 0.200 - Beat
![Wall Street Horizon](../../../Content/images/providers/WH.png)
Pyxis Oncology, Inc. (PYXS)
Company Research
Source: Wall Street Horizon
![Wall Street Horizon](../../../Content/images/providers/WH.png)
Impact Snapshot
Event Time:
PYXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PYXS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PYXS alerts
High impacting Pyxis Oncology, Inc. news events
Weekly update
A roundup of the hottest topics
PYXS
News
- Institutional owners may ignore Pyxis Oncology, Inc.'s (NASDAQ:PYXS) recent US$25m market cap decline as longer-term profits stay in the green [Yahoo! Finance]Yahoo! Finance
- Pyxis Oncology Expands Board of Directors with Appointment of Michael A. MetzgerGlobeNewswire
- Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare ConferenceGlobeNewswire
- Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.MarketBeat
- Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024 [Yahoo! Finance]Yahoo! Finance
PYXS
Earnings
- 11/7/23 - Beat
PYXS
Sec Filings
- 6/12/24 - Form 8-K
- 6/10/24 - Form 4
- 6/10/24 - Form 3
- PYXS's page on the SEC website